TNFSF10 and asthma: While some studies, mainly based on the use of TRAIL-/- knock out mouse models [4], [6], point on a pro-inflammatory role of endogenous TRAIL, a more recent study has demonstrated that recombinant TRAIL administration might rather plays a role in the resolution phase of asthma, by promoting apoptosis of infiltrating leukocytes [9].